Yuav Ua Li Cas Xaiv Microfiltration lossis Ultrafiltration membranes cassettes?

Apr 30, 2026|

Microfiltration (MF) - Precise particulate controls for biopharma processes

Microfiltration membranes nrog 0.1-0.5 µm pores kom tshem tawm cov khib nyiab, sediments thiab cov kab mob loj dua, xa cov dej ntshiab, qis -turbidity txheej txheem. Hauv biopharmaceutical manufacturing MF yog qhov zoo rau:

  • Clarifying cell kab lis kev cai supernatant thiab fermentation broths
  • Tiv thaiv cov khoom siv hauv qab los ntawm kev txo cov khoom seem thiab fouling
  • Ua haujlwm tseem ceeb hauv dej- rau- cov txheej txheem thiab cov dej siv hluav taws xob

 

Cov txiaj ntsig tseem ceeb: kev ua haujlwm siab, tsis tshua muaj siab ua haujlwm, ncua lub neej ntawm cov dej hauv qab. Faj seeb: MF tsis tshem cov ntsev yaj, cov organic uas tsis muaj molecular-hnyav los yog cov kab mob uas muaj kev ntseeg siab tau - siv ua ib feem ntawm ntau theem purification tsheb ciav hlau.

 

Ultrafiltration (UF) - Concentration thiab fine-particle tshem tawm nrog molecular selectivity

Ultrafiltration nta tighter pores (~ 0.01–0.1 µm; MWCO qhia hauv kDa) khaws cov kab mob, colloids thiab loj biomolecules. UF feem ntau yog siv rau:

  • Protein concentration thiab tsis pauv pauv (diafiltration)
  • Advanced clarification ntawm fermentation thiab cell culture effluent
  • Txo cov colloidal thiab siab-molecular-hnyav impurities ua ntej kawg purification
  • Txhawb nqa tus kab mob-txo cov haujlwm ua haujlwm thaum ua ke nrog cov lim dej tshem tawm cov kab mob uas tau lees paub

Cov txiaj ntsig tseem ceeb: zoo macromolecule tuav, scalable flux tus nqi, qis zog piv nrog RO. UF ntxiv rau- ntau dua li hloov - ua kom tsis muaj menyuam lossis cov kab mob tshem tawm.

 

Vim li cas thiaj koom ua ke MF thiab UF hauv cov nroj tsuag biopharma?

  • Optimized multi-theem tiv thaiv: MF txo cov khoom khib nyiab thiab tiv thaiv UF/sterilizing lim, txhim kho uptime thiab txo nqi lifecycle.
  • GMP thiab validation npaj: daim nyias nyias muaj nyob rau hauv pharmacopeia-qib cov ntaub ntawv uas txhawb CIP / SIP, kev ntsuam xyuas ncaj ncees thiab niaj hnub txheej txheem validation.
  • Kev xa tawm yooj yim: cov qauv tsim tau yooj yim rau kev tsav mus rau kev lag luam tsim khoom, sib xws nrog cov protein, tshuaj tiv thaiv thiab cov txheej txheem tshuaj tsis muaj menyuam.
  • Kev tswj hwm & kev ua haujlwm tseem ceeb

 

Xaiv cov ntaub ntawv membrane thiab kev teeb tsa uas txhawb nqa CIP / SIP thiab kev kuaj xyuas qhov tseeb.

Ua raws li niaj hnub microbial, endotoxin thiab kev saib xyuas kev ncaj ncees kom ua tau raws li GMP kev cia siab.

Siv MF/UF raws li ib feem ntawm kev siv tau, ntau lub tswv yim rau kev nyab xeeb ntawm cov khoom thiab cov txheej txheem robustness.

Pib

 

Tham nrog peb cov kws kho mob tshwj xeeb los tsim cov tshuaj MF/UF uas haum rau koj daim ntawv thov biopharma-kev qhia meej, kev xav, lossis kev tiv thaiv sab saud/kem.

Xa kev nug